Feb
That recent article was not the first to make this suggestion, but it is getting press because it is the latest, and the most scientifically sound. It was placebo controlled, meaning some in the study merely got sterile normal saline injected. In addition, surprisingly, patients did not guess correctly if they got Botox or the placebo, but the ones who did get the Botox had improvement of their depression. The patients on the “control” or placebo side did not. This could be related to Botox’s effect on neurotransmitter uptake and/or the muscles being relaxed, having a feedback to the brain improving brain chemistry in the depressed. This certainly warrants further study, but needless to say it suggests yet another benefit to this amazing drug.
I am asked this question often. Many things in nature can have therapeutic effects in tiny doses, but the same drug found in nature (after all, Botox is a purified protein found in nature) can have toxic effects at high doses. Modern medical scientific research has found many compounds in nature to improve illness. One of my favorites is digitalis, a heart drug to improve the ejection of blood from a failing heart. This drug was found in nature and is also toxic in some doses, yet saves the lives and improves the quality of lives in millions with congestive heart failure every day when used in tiny doses.
Yes, Merz US distributes Xeomin, a new neuromodulators. In clinical trial it behaved similarly to Botox. I have used it in any patient who wants to try it to compare and see if it might work better or longer than Botox in them.
Our mission at the Lupo Center is to provide patients with innovative, effective, and ethical care to make each person look and feel their personal best. To fulfill our goal, we provide state-of-the-art medical, surgical, and cosmetic treatments to all patients.
Board-certified dermatologist and clinical professor of dermatology Mary P. Lupo, MD, has been a leader in the field of non-surgical rejuvenation since 1983. She travels internationally to teach her innovative techniques, and her reputation brings in patients from around the country. She started the first formal residency training program for injectables and peels in 1983 at Tulane Medical School and served as past president of the Women’s Dermatologic Society, adjunct professor of dermatology at Tulane, and a founder of Cosmetic Boot Camp. Dr. Lupo holds membership in many prestigious dermatology associations, participates in clinical trials for the approval of new drugs and devices, and acts as an advisor for numerous aesthetic-minded companies.
Dr. Lupo was recently recognized as a trailblazer for women in dermatology and for her dedication to educating dermatology residents and fellows.
She has also received the following awards:
Dr. Lupo has authored over 90 published articles and book chapters and has spoken on various dermatological topics at nearly 480 national and international meetings and seminars.
